Balance Sheet
Accounts PayablesAccumulated ExpensesAssetsCash & Current InvestmentsCash & EquivalentsCommon EquityConvertible DebtCurrent AssetsCurrent Deferred RevenueCurrent LeasesFinished GoodsGoodwillGoodwill & IntangiblesIntangiblesInventoryLiabilities and Shareholders EquityLong-Term Deferred TaxNon-Current AssetsNotes PayablesOperating LeasesOther Accumulated ExpensesOther Non-Current AssetsOther Non-Current LiabilitiesPayablesPrepaid AssetsProperty, Plant & Equipment (Net)Property, Plant & Equipment (Net)Raw MaterialsReceivablesReceivables - NetReceivables - OtherRetained EarningsShareholder's EquityShares OutstandingTotal Current LiabilitiesTotal LiabilitiesTotal Non-Current LiabilitiesTreasury SharesTreasury SharesWork In Process
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Dexcom (DXCM) Short-term Investments (2016 - 2017)

Dexcom has reported Short-term Investments over the past 8 years, most recently at $107.1 million for Q4 2017.

  • Quarterly Short-term Investments rose 266.78% to $107.1 million in Q4 2017 from the year-ago period, while the trailing twelve-month figure was $107.1 million through Dec 2017, up 266.78% year-over-year, with the annual reading at $107.1 million for FY2017, 266.78% up from the prior year.
  • Short-term Investments was $107.1 million for Q4 2017 at Dexcom, down from $123.7 million in the prior quarter.
  • Over five years, Short-term Investments peaked at $123.7 million in Q3 2017 and troughed at $11.4 million in Q4 2013.
  • The 5-year median for Short-term Investments is $28.0 million (2015), against an average of $35.4 million.
  • Year-over-year, Short-term Investments tumbled 71.92% in 2013 and then soared 317.91% in 2017.
  • A 5-year view of Short-term Investments shows it stood at $11.4 million in 2013, then grew by 3.51% to $11.8 million in 2014, then surged by 146.61% to $29.1 million in 2015, then grew by 0.34% to $29.2 million in 2016, then surged by 266.78% to $107.1 million in 2017.
  • Per Business Quant, the three most recent readings for DXCM's Short-term Investments are $107.1 million (Q4 2017), $123.7 million (Q3 2017), and $100.7 million (Q2 2017).